JPWO2020214846A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020214846A5 JPWO2020214846A5 JP2021562003A JP2021562003A JPWO2020214846A5 JP WO2020214846 A5 JPWO2020214846 A5 JP WO2020214846A5 JP 2021562003 A JP2021562003 A JP 2021562003A JP 2021562003 A JP2021562003 A JP 2021562003A JP WO2020214846 A5 JPWO2020214846 A5 JP WO2020214846A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- cell penetrating
- cargo
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1904115 | 2019-04-17 | ||
| FR1904115 | 2019-04-17 | ||
| PCT/US2020/028572 WO2020214846A1 (en) | 2019-04-17 | 2020-04-16 | Peptides and nanoparticles for intracellular delivery of molecules |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022529784A JP2022529784A (ja) | 2022-06-24 |
| JP2022529784A5 JP2022529784A5 (https=) | 2023-04-24 |
| JPWO2020214846A5 true JPWO2020214846A5 (https=) | 2023-04-24 |
| JP7715638B2 JP7715638B2 (ja) | 2025-07-30 |
Family
ID=72837882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562003A Active JP7715638B2 (ja) | 2019-04-17 | 2020-04-16 | 分子を細胞内送達するためのペプチドおよびナノ粒子 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12357695B2 (https=) |
| EP (1) | EP3955967A4 (https=) |
| JP (1) | JP7715638B2 (https=) |
| CN (1) | CN114007654A (https=) |
| AU (1) | AU2020259449A1 (https=) |
| CA (1) | CA3137137A1 (https=) |
| IL (1) | IL287321A (https=) |
| MX (1) | MX2021012740A (https=) |
| WO (1) | WO2020214846A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021012740A (es) | 2019-04-17 | 2022-01-24 | Aadigen Llc | Péptidos y nanopartículas para entrega intracelular de moléculas. |
| WO2023081893A1 (en) * | 2021-11-08 | 2023-05-11 | Entrada Therapeutics, Inc. | Intracellular targeting of oligonucleotides |
| WO2023111213A1 (en) | 2021-12-16 | 2023-06-22 | Rdp Pharma Ag | Cell penetrating polypeptides (cpps) and their use in human therapy |
| EP4545552A1 (en) * | 2022-06-22 | 2025-04-30 | Toagosei Co., Ltd. | Carrier peptide fragment and use thereof |
| NL2033185B1 (en) * | 2022-09-29 | 2024-04-08 | Stichting Vu | Compounds for rna stabilisation and delivery |
| WO2024187174A2 (en) * | 2023-03-09 | 2024-09-12 | Aadigen, Llc | Compositions for treating cancer with kras mutations and uses thereof |
| EP4480497A1 (en) | 2023-06-21 | 2024-12-25 | RDP Pharma AG | Bio-conjugates for oncology |
| WO2025193628A2 (en) * | 2024-03-09 | 2025-09-18 | Aadigen, Llc | Compositions for treating cancer with kras mutations and uses thereof |
| FR3163973A1 (fr) | 2024-06-27 | 2026-01-02 | Safran Aircraft Engines | Compresseur axial a traitement de carter pour une turbomachine d’aeronef |
| CN119954937B (zh) * | 2024-12-26 | 2025-09-12 | 东北农业大学 | 一种源自节肢蛋白的抗菌肽及其制备方法和应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305812A3 (en) | 2002-11-14 | 2012-06-06 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| US7514530B2 (en) | 2004-04-26 | 2009-04-07 | Centre National De La Recherche Scientifique | Peptide carrier for delivering siRNA into mammalian cells |
| US7579318B2 (en) | 2005-12-06 | 2009-08-25 | Centre De La Recherche De La Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| EP4032552B1 (en) | 2008-08-26 | 2023-10-04 | City of Hope | Method and compositions for enhanced anti-tumor effector functioning of t cells |
| US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
| DK2631291T3 (da) | 2010-10-22 | 2019-06-11 | Olix Pharmaceuticals Inc | Nukleinsyremolekyler, der inducerer rna-interferens, og anvendelser deraf |
| US20140065615A1 (en) | 2011-03-21 | 2014-03-06 | Yale University | The KRAS Variant and Tumor Biology |
| WO2012137036A1 (en) | 2011-04-04 | 2012-10-11 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| EP2782926B1 (en) * | 2011-11-24 | 2018-07-04 | Positec Power Tools (Suzhou) Co., Ltd | Peptide sequence design and use thereof for peptide-mediated sirna delivery |
| JP2013212052A (ja) | 2012-03-30 | 2013-10-17 | Yale Univ | Ｋｒａｓバリアントおよび腫瘍生物学 |
| AU2013243948A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins associated with human disease |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013150338A1 (en) | 2012-04-04 | 2013-10-10 | Centre National De La Recherche Scientifique | Stapled cell penetrating peptides for intracellular delivery of molecules |
| EA033110B1 (ru) | 2012-04-11 | 2019-08-30 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерный рецептор антигена, направленный на антиген созревания b-клеток, кодирующая его нуклеиновая кислота, соответствующие экспрессионный вектор, клетка-хозяин, применения и способы |
| ES2981865T3 (es) * | 2012-07-11 | 2024-10-10 | Gemvax & Kael Co Ltd | Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo |
| SG11201502954TA (en) | 2012-07-16 | 2015-05-28 | Kyowa Hakko Kirin Co Ltd | Rnai pharmaceutical composition for suppressing expression of kras gene |
| WO2014053881A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053882A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053880A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014099671A1 (en) | 2012-12-20 | 2014-06-26 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| ITRM20130054A1 (it) | 2013-01-30 | 2014-07-31 | Paolo Gresele | Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi. |
| EP4303232A3 (en) | 2013-02-15 | 2024-04-17 | The Regents of The University of California | Chimeric antigen receptor and methods of use thereof |
| EP3237436B1 (en) * | 2014-12-24 | 2019-05-01 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of molecules |
| EP3444345B1 (en) | 2016-04-14 | 2024-07-10 | e-NA Biotec Inc. | microRNA-143 DERIVATIVE |
| US20190211317A1 (en) | 2016-05-27 | 2019-07-11 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of genome-editing molecules |
| AU2017268842B2 (en) * | 2016-05-27 | 2022-08-11 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of genome-editing molecules |
| EP3665285A4 (en) * | 2017-08-10 | 2021-08-11 | Aadigen, LLC | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR VIRUS ADMINISTRATION |
| US20200323964A1 (en) | 2017-10-16 | 2020-10-15 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of mrna |
| MX2021012740A (es) | 2019-04-17 | 2022-01-24 | Aadigen Llc | Péptidos y nanopartículas para entrega intracelular de moléculas. |
| CA3181170A1 (en) | 2020-04-24 | 2021-10-28 | Aadigen, Llc | Compositions for treating cancer with kras mutations and uses thereof |
| CN116724059A (zh) | 2020-07-24 | 2023-09-08 | 阿迪根有限公司 | 用于治疗病毒感染的组合物和方法 |
-
2020
- 2020-04-16 MX MX2021012740A patent/MX2021012740A/es unknown
- 2020-04-16 JP JP2021562003A patent/JP7715638B2/ja active Active
- 2020-04-16 US US17/594,454 patent/US12357695B2/en active Active
- 2020-04-16 CN CN202080044200.0A patent/CN114007654A/zh active Pending
- 2020-04-16 CA CA3137137A patent/CA3137137A1/en active Pending
- 2020-04-16 EP EP20792117.2A patent/EP3955967A4/en active Pending
- 2020-04-16 AU AU2020259449A patent/AU2020259449A1/en active Pending
- 2020-04-16 WO PCT/US2020/028572 patent/WO2020214846A1/en not_active Ceased
-
2021
- 2021-10-17 IL IL287321A patent/IL287321A/en unknown
-
2025
- 2025-06-11 US US19/235,292 patent/US20250302963A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7772201B2 (en) | Highly branched HK peptides as effective carriers of siRNA | |
| KR101617790B1 (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| US9415114B2 (en) | Conformations of divergent peptides with mineral binding affinity | |
| JP2010526091A (ja) | 癌の処置のための生物学的な標的基の改変 | |
| JP2010526091A5 (https=) | ||
| JPH09508530A (ja) | 核酸を含む組成物、その調製および使用 | |
| US9849190B2 (en) | Peptide having cancer selective translocation function and use thereof | |
| JPWO2020214846A5 (https=) | ||
| CN114540416A (zh) | 一种表达载体、脂质纳米粒、抗肿瘤药物及其制备方法和用途 | |
| JP7644105B2 (ja) | 核酸治療薬のための腫瘍標的化ポリペプチドナノ粒子送達システム | |
| CN113058042A (zh) | 一种可鼻喷的稳定递载rna分子的脂质纳米颗粒制备方法 | |
| WO2023093596A1 (zh) | 一种用于有效递送核酸的环状多肽载体及其变化形式 | |
| US20250332275A1 (en) | Branched Polypeptide Carrier for Efficient Nucleic Acid Delivery and Its Variants | |
| JP2023539460A (ja) | 薬剤と野生型膜透過ペプチド誘導体の組成物 | |
| KR20240035722A (ko) | 세포 내 형질주입을 위한 신규한 폴리펩타이드 조성물 | |
| CN114452397A (zh) | 药物递送载体和使用其共递送多种治疗剂的药物制剂 | |
| JP2025534459A (ja) | 細胞透過性ペプチド及びその使用 | |
| EP2108698A1 (en) | Vascular endothelial cell-binding peptide | |
| CN115260286A (zh) | Dmp-f11多肽偶联物及其制备方法和用途 | |
| CN118949060B (zh) | 一种包裹siRNA的具有线粒体靶向功能的酶响应性多肽纳米药物及其制备方法 | |
| US20230121879A1 (en) | Methods for preparing nanoparticle compositions containing histidine-lysine copolymers | |
| CN116813714A (zh) | 一种注射型药物缓释肽水凝胶及其制备方法 | |
| US20230233476A1 (en) | Nanoparticle pharmaceutical compositions with reduced nanoparticle size and improved polydispersity index | |
| Rahman et al. | Peptide-based anticancer targeted therapeutics: state of the art | |
| CN121338022A (zh) | Dmp-g9多肽偶联物及其制备方法和用途 |